Avanos Medical, Inc. announced that Dr. Lisa Egbuonu-Davis, currently vice president, medical innovations, for DH Diagnostics, LLC, has been appointed as a new independent member of the Avanos board of directors and will serve as a member of the compliance and governance committees. From 2015 to 2019, Egbuonu-Davis served as vice president, global patient centered outcomes and solutions, at Sanofi, Inc., where she created patient programs, services, and tools to enhance health outcomes in patients with chronic conditions. Prior to Sanofi, Egbuonu-Davis co-founded and served as director for ROI Squared, LLC, a privately held life science company focused on diagnostic medical devices, and served as managing director for LED Enterprise, LLC, where she advised biopharmaceutical companies and trade associations on healthcare reform, technology assessment, quality metrics, and incentives and implications for research and services.

She also served in senior advisor roles for Avalere Health and Booz Allen Hamilton, as well as in various roles over 13 years at Pfizer, Inc., where she led clinical and outcomes research departments, supported product value assessments in support of reimbursement and adoption, and influenced product investment and development decisions. Egbuonu-Davis earned a bachelor's degree in biology from MIT and an MBA in healthcare management from Wharton, as well as an M.D. and an M.S. in public health from Johns Hopkins. She completed her pediatric residency at Children's Hospital of Philadelphia (board-certified in pediatrics).

She has served on the Johns Hopkins Medicine board of trustees since 2021 and the national advisory council for the Johns Hopkins University School of Education since 2007. With this new appointment, the Avanos board now comprises six directors, five of whom are independent, including two women, one of whom is ethnically diverse.